SLFN14
Basic information
Region (hg38): 17:35543985-35560819
Links
Phenotypes
GenCC
Source:
- platelet-type bleeding disorder 20 (Strong), mode of inheritance: AD
- platelet-type bleeding disorder 20 (Supportive), mode of inheritance: AD
- platelet-type bleeding disorder 20 (Moderate), mode of inheritance: AD
- platelet-type bleeding disorder 20 (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bleeding disorder, platelet-type, 20 | AR | Hematologic | Individuals have increased bleeding tendency, and awareness may allow preventive measures and early management of bleeding complications | Hematologic | 26280575; 26769223 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLFN14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 55 | 70 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 1 | 60 | 12 | 21 |
Variants in SLFN14
This is a list of pathogenic ClinVar variants found in the SLFN14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-35548243-T-A | Platelet-type bleeding disorder 20 | Benign (Jul 15, 2021) | ||
17-35548254-C-T | SLFN14-related disorder | Likely benign (May 15, 2018) | ||
17-35548265-G-A | Platelet-type bleeding disorder 20 | Benign (Jul 15, 2021) | ||
17-35548286-C-G | Uncertain significance (Nov 06, 2017) | |||
17-35548292-A-G | Abnormal bleeding;Thrombocytopenia | Uncertain significance (May 01, 2020) | ||
17-35548340-TA-T | Platelet-type bleeding disorder 20 | Uncertain significance (Sep 03, 2021) | ||
17-35548353-G-A | Inborn genetic diseases | Likely benign (Feb 06, 2024) | ||
17-35548402-T-C | Inborn genetic diseases | Uncertain significance (May 21, 2024) | ||
17-35548418-C-T | Inborn genetic diseases | Uncertain significance (Mar 02, 2023) | ||
17-35548426-G-A | Uncertain significance (Nov 12, 2019) | |||
17-35548435-A-C | Inborn genetic diseases | Uncertain significance (Jun 10, 2024) | ||
17-35548454-G-T | SLFN14-related disorder | Uncertain significance (Jun 04, 2024) | ||
17-35548506-G-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 01, 2022) | ||
17-35548523-A-G | Inborn genetic diseases | Uncertain significance (Aug 08, 2022) | ||
17-35548559-G-T | not specified • Inborn genetic diseases | Uncertain significance (Jul 05, 2022) | ||
17-35548669-T-A | SLFN14-related disorder | Likely benign (Dec 11, 2023) | ||
17-35548687-A-G | Inborn genetic diseases | Uncertain significance (Feb 12, 2024) | ||
17-35548717-G-A | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
17-35548762-G-A | Inborn genetic diseases | Uncertain significance (Nov 23, 2021) | ||
17-35548771-A-G | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) | ||
17-35548778-A-C | Inborn genetic diseases | Uncertain significance (Apr 20, 2024) | ||
17-35548791-G-C | SLFN14-related disorder | Benign (Sep 11, 2018) | ||
17-35548804-C-T | Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | ||
17-35548824-AG-A | Platelet-type bleeding disorder 20 | Uncertain significance (Aug 10, 2018) | ||
17-35548832-G-A | Platelet-type bleeding disorder 20 | Uncertain significance (Aug 10, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLFN14 | protein_coding | protein_coding | ENST00000415846 | 4 | 9974 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.51e-9 | 0.929 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.43 | 318 | 465 | 0.684 | 0.0000225 | 6013 |
Missense in Polyphen | 89 | 137.81 | 0.64581 | 1859 | ||
Synonymous | 2.20 | 134 | 170 | 0.786 | 0.00000838 | 1732 |
Loss of Function | 1.90 | 18 | 29.1 | 0.619 | 0.00000152 | 403 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein SLFN14: Shows no ribosome-associated and endoribonuclease activities. {ECO:0000269|PubMed:25996083}.;
Intolerance Scores
- loftool
- rvis_EVS
- 2.71
- rvis_percentile_EVS
- 98.93
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.310
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Slfn14
- Phenotype
Gene ontology
- Biological process
- mRNA catabolic process;rRNA catabolic process;platelet maturation;cellular response to magnesium ion;cellular response to manganese ion;RNA phosphodiester bond hydrolysis, endonucleolytic
- Cellular component
- nucleus;cytoplasm
- Molecular function
- endoribonuclease activity;ATP binding;ribosome binding